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There are a wide variety of devices that have been utilized for transcatheter PFO closure. We aimed to perform a meta-analysis of safety and efficacy 
outcomes reported in the literature, stratified by the device type.
Methods: Medline search was performed and all studies reporting safety and efficacy related outcomes in patients undergoing PFO closure for 
prevention of recurrent neurological events (RNE) after presumed paradoxical thromboembolism, were included.
Results: A total of 121 studies were included for review. We observed that Amplatzer has been the most common device utilized for closure, 
followed by CardioSEAL, Intrasept, Starflex and Helex devices respectively. Of the most common devices utilized, Helex had the lowest RNE rate in 
the follow up period [0.10 events/ 100 PY], followed by Amplatzer [0.60 events/ 100 PY] and Starflex devices [0.60 events/ 100 PY]. Amplatzer, 
Premere and Helex devices were associated with the lowest composite complication rates. CardioSEAL and Starflex devices were associated with 
the highest rate of atrial arrhythmias and Premere and Helex devices were associated with the lowest risk of atrial arrhythmias. The risk of thrombus 
formation was highest with the Starflex devices and lowest with the Helex devices. It was observed that the Helex devices were most common 
devices to embolize.
Conclusions: Despite the heterogeneity observed in the rates of complications with various devices, the rates of RNE after device closure remain 
low with all major device types. 
Amplatzer CardioSEAL Starflex Premere Helex PFOStar Cardia
n 5988 1658 1221 657 1396 827 473
Procedural Failures 0.01(0 - 0.2)
0.01
(0 - 0.3)
0.1
(0 - 0.6)
0.01
(0 - 0.7)
0.1
(0 - 0.4)
0.01
(0 - 0.6)
0.01
(0 - 0.5)
Effusion or Tamponade 0.2(0 - 0.8)
0
(0 - 2.6)
0
(0 - 0.8)
0
(0 - 2.6)
0.5
(0 - 1.7)
0.2
(0 - 1.1)
0.7
(0 - 1.7)
Embolization/ Malposition 0.1(0 - 0.4)
0.4
(0 - 1.0)
0.6
(0 - 1.9)
0
(0 - 4.6)
1.6
(0.1 - 3.1)
0.8
(0 - 1.8)
0.5
(0 - 1.4)
Thrombus 0.2(0 - 0.6)
0.4
(0 - 0.9)
3.2
(1.4 - 4.9)
1.3
(0 - 3.8)
0
(0 - 0.7)
2.9
(1.1 - 4.7)
2.6
(0.8 - 4.4)
Atrial Arrhythmia 2.0(1.3 - 2.7)
10.8
(8.1 - 13.4)
9.7
(6.6 - 12.7)
1.7
(0 - 3.6)
1.8
(0.3 - 3.3)
2.3
(0.5 - 4.0)
5.4
(2.9 - 7.8)
Bleeding complications 1.2(0.2 - 2.2)
1.5
(0.3 - 2.7)
0.2
(0 - 1.0)
1.3
(0 - 5.0)
0.9
(0 - 2.1)
4.4
(0 - 10.5)
0
(0 - 0.5)
Reintervention 0.9(0.5 - 1.4)
0.7
(0 - 3.7)
1.5
(0 - 3.1)
2.7
(0.3 - 5.1)
3.2
(1.6 - 4.7)
1.0
(0 - 3.8)
7.8
(0 - 24.9)
Surgical Intervention 0.3(0 - 0.8)
0.5
(0 - 1.0)
2.2
(0 - 4.5) -
0
(0 - 1.7)
0.8
(0 - 2.0)
0
(0 - 0.5)
Related death 0(0 - 0.3)
0
(0 -0.4)
0
(0 - 1.1)
0
(0 - 2.6)
0
(0 - 1.4)
0
(0 - 1.0) -
Any above complication 0.8 per 100 PY(0.4 - 1.1)
3.4 per 100 PY
(1.6 - 5.2)
3.5 per 100 PY
(1.3 - 5.6)
0.8 per 100 PY
(0.2 - 1.5)
0.9 per 100 PY
(0 - 1.9)
4.0 per 100 PY
(1.1 - 6.8)
2.9 per 100 PY
(1.9 - 3.9)
Recurrent neurological events 0.6 per 100 PY(0.3 - 0.8)
1.1 per 100 PY
(0.5 - 1.6)
0.6 per 100 PY
(0 - 1.3)
1.0 per 100 PY
(0 - 3.0)
0.1 per 100 PY
(0 - 0.5)
1.5 per 100 PY
(0.2 - 2.8)
1.1 per 100 PY
(0.5 - 1.6)
Residual Shunt
Post-procedure 16.1(10.2 - 22.0)
18.5
(9.8 - 27.1)
33.6
(19.1 - 48.1)
36.1
(22.0 - 50.2)
46.1
(23.7 - 68.5)
46.9
(36.5 - 57.3)
23.6
(18.8 - 28.4)
12 months or less 4.3(2.5 - 6.1)
10.5
(5.2 - 15.8)
8.5
(4.7 - 12.3)
8.8
(1.7 - 15.9)
11.4
(1.2 - 21.6)
13.3
(4.1 - 22.5)
9.7
(0 - 23.5)
More than 12 months 3.0(0.6 - 5.4)
1.5
(0 - 4.9)
1.8
(0 - 3.6)
7.7
(3.9 - 11.5)
10.2
(0 - 22.1)
25
(0 - 94.3) -
Table 1: Percentage incidence of device related complications for commonly used devices. The values are expressed as Percent incidence (95 % confidence interval). Abbreviation: PY: person-years
